BackProQR Therapeutics N.V Overview
ProQR Therapeutics N.V

ProQR Therapeutics N.V Discounted Cash Flow

DCF Analysis for PRQR.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$-0.67

Current Fair Value

$-0.67
135.2% Downside

Overvalued by 135.2% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading